Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases

University of Aarhus

Status: Completed

Conditions: Malnutrition; Liver Diseases, Alcoholic

Treatments: Device: Gastric tube (Nutricia Flocare® Pur Tube Enlock); Device: Jejunal tube (Nutricia Flocare® Bengmark®)

Study type: Interventional

Funder types: Other

Identifiers

NCT02319252

Tubes in liver diseases

Details and patient eligibility

About

The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal feeding tubes are the most effect full to feed patients with alcoholic liver diseases and non-sufficient oral intake.

The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea & vomiting.

The study will include 40 patients at Aarhus University Hospital, Denmark.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Alcoholic liver disease
• nutrition intake less than 75% of needed intake
• Signed informed consent form

Exclusion criteria

• Hepatic encephalopathy, grade 3 - 4
• Anatomic barriers to have a tube placed

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Gastric tube

Active Comparator group

Description:

A gastric tube is used

Treatment:

Device: Gastric tube (Nutricia Flocare® Pur Tube Enlock)

Jejunal tube

Active Comparator group

Description:

A jejunal tube is used

Treatment:

Device: Jejunal tube (Nutricia Flocare® Bengmark®)